title: [The choice of the uterine-contraction agent in managing the placental period of labor based on our data].
abstract: Every obstetrician is acquainted with the existing risk during the placental stage. The danger of a greater blood loss is always present. The use of uterotonic medicines reduces the post-delivery bleeding. The authors have carried out observations over 422 delivery cases. In 153 of them ergotamine has been applied in the placental stage, in 121 oxytocine, and in 148 delivery cases the placental stage has passed without uterotonic drugs. The authors have concluded that the application of contracting medicines reduces the blood loss, but their usage has to be selective and after delivery of the fore shoulder of the foetus.
authors.forename: D
authors.initials: D
authors.lastname: Kichukova
authors.forename: N
authors.initials: N
authors.lastname: Milchev
authors.forename: V
authors.initials: V
authors.lastname: Paskaleva
authors.forename: M
authors.initials: M
authors.lastname: Malinova
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007749:Labor Stage, Third / Q000187:drug effects*; D008755:Methylergonovine; D007744:Obstetric Labor Complications / Q000517:prevention & control; D010120:Oxytocics; D010121:Oxytocin; D011247:Pregnancy; D012307:Risk Factors; D013997:Time Factors; D014592:Uterine Hemorrhage / Q000517:prevention & control
chemical_list: D010120:Oxytocics; D010121:Oxytocin; D008755:Methylergonovine
vernacular_title: Izbor na kontrakhirashto sredstvo pri vodene na platsentarniia period na razhdaneto po nash material.